Oximes

acetylcholinesterase ; Rattus norvegicus







63 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33540058 Potential role of a newly AChE reactivator in the depressive-like behavior induced by malathion. 2021 Apr 1 2
2 33545185 Determination of K869, a Novel Oxime Reactivator of Acetylcholinesterase, in Rat Body Fluids and Tissues by Liquid-Chromatography Methods: Pharmacokinetic Study. 2021 Apr 3
3 31158460 Novel centrally active oxime reactivators of acetylcholinesterase inhibited by surrogates of sarin and VX. 2020 Jan 1
4 31694074 Pre-clinical evidence of safety and protective effect of isatin and oxime derivatives against malathion-induced toxicity. 2020 Apr 1
5 32319115 Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates. 2020 Nov 3
6 32436233 Positron emission tomography evaluation of oxime countermeasures in live rats using the tracer O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate [18 F]-VXS. 2020 Nov 4
7 32502538 Antidepressant-like effect of (3Z)-5-Chloro-3-(hydroxyimino)indolin-2-one in rats exposed to malathion: Involvement of BDNF-Trkβ pathway and AChE. 2020 Sep 1 1
8 29722548 In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators. 2019 Jul 2
9 29098328 Effect of six oximes on acutely anticholinesterase inhibitor-induced oxidative stress in rat plasma and brain. 2018 Feb 1
10 29482737 Kinetic analysis of oxime-assisted reactivation of human, Guinea pig, and rat acetylcholinesterase inhibited by the organophosphorus pesticide metabolite phorate oxon (PHO). 2018 Feb 1
11 30176331 Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats. 2018 Sep 1 1
12 28696367 The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203. 2017 Jul 11 4
13 29091431 Application of the Ugi Multicomponent Reaction in the Synthesis of Reactivators of Nerve Agent Inhibited Acetylcholinesterase. 2017 Nov 22 2
14 27129421 Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity. 2016 Nov 25 1
15 27177985 Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor. 2016 Jul 3
16 25461321 Discovery of non-oxime reactivators using an in silico pharmacophore model of reactivators for DFP-inhibited acetylcholinesterase. 2015 Jan 27 2
17 25894563 A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice. 2015 Mar 2
18 22901042 The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. 2013 Feb 1
19 23123249 Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates. 2013 Mar 25 6
20 23422169 An acetylcholinesterase-inspired biomimetic toxicity sensor. 2013 May 3
21 22696932 The ability of oxime mixtures to increase the reactivating and therapeutic efficacy of antidotal treatment of cyclosarin poisoning in rats and mice. 2012 2
22 20569082 Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators. 2011 Feb 1
23 21954536 Biochemical insight into soman intoxication and treatment with atropine, HI-6, trimedoxime, and K203 in a rat model. 2011 1
24 19746406 The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice. 2010 Mar 4
25 20167212 Tabun-inhibited rat tissue and blood cholinesterases and their reactivation with the combination of trimedoxime and HI-6 in vivo. 2010 Sep 6 2
26 18686075 An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice. 2009 Jan 1
27 19338015 Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy. 2009 Aug 1
28 19552519 A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice. 2009 Aug 1
29 19603416 Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure? 2009 Aug 2
30 17964625 Blood-brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS. 2008 Feb 15 2
31 18547554 A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats. 2008 Sep 25 4
32 18608751 A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice. 2008 Dec 2
33 18991751 Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy. 2008 Nov 5
34 17674811 A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats. 2007 Jun 3
35 16766478 In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase. 2006 Aug 1
36 16952906 A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. 2006 Oct 5
37 17265677 Substituted monoquaternary oximes as reactivators of cyclosarin--and chlorpyrifos--inhibited acetylcholinesterase. 2006 Dec 2
38 15901095 A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods. 2005 Apr 23 3
39 16025528 In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. 2005 Jul-Aug 1
40 16170392 New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications. 2005 Jun 2
41 16259317 A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. 2005 5
42 16393932 Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing. 2005 Nov-Dec 1
43 16601802 A comparison of the potency of trimedoxime and other currently available oximes to reactivate tabun-inhibited acetylcholinesterase and eliminate acute toxic effects of tabun. 2005 Dec 3
44 15033007 [Protective effect of memantine on N-methyl-D-aspartate receptor in dichlorvos-poisoned rat brain]. 2004 Feb 2
45 15171567 Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent. 2004 Apr 1
46 15446359 In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048. 2004 1
47 12893843 Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design. 2003 Oct 3
48 15008517 A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. 2003 Dec 1
49 10566233 [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats]. 1999 Aug 30 1
50 9543466 Preclinical pharmacology of metrifonate. 1998 Mar-Apr 1